☆ 4.7 Article

Profile and outcome of cancer patients enrolled in contemporary phase I trials

EUROPEAN JOURNAL OF CANCER (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Cancer statistics for the year 2020: An overview

Jacques Ferlay et al.

Summary: The study briefly reviews the methods and data sources used in compiling the IARC GLOBOCAN cancer statistics for 2020 and summarizes the main results. It estimated that there were nearly 19.3 million new cancer cases and almost 10 million cancer deaths worldwide in 2020, with the most commonly diagnosed cancers being female breast cancer and lung cancer, and the most common causes of cancer death being lung cancer and liver cancer.

INTERNATIONAL JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States

Shrunjal Shah et al.

Summary: The incidence of lung neuroendocrine tumors is increasing, and survival trends are influenced by various factors including stage, histological type, age, race, marital status, and insurance type. Challenges still exist in early detection and treatment.

CANCERS (2021)

Add to Collection

Letter Oncology

Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic

Arnaud Bayle et al.

CANCER CELL (2021)

Add to Collection

Article Oncology

Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index

Daphne Day et al.

JNCI CANCER SPECTRUM (2019)

Add to Collection

Review Genetics & Heredity

Evolution of early phase clinical trials in oncology

Nam Q. Bui et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2018)

Add to Collection

Letter Medicine, General & Internal

Encouraging Trends in Modern Phase 1 Oncology Trials

Camille Chakiba et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Review Oncology

The changing landscape of phase I trials in oncology

Kit Man Wong et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Add to Collection

Article Medicine, General & Internal

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection

Review Oncology

Evolution of Clinical Trial Design in Early Drug Development: Systematic Review of Expansion Cohort Use in Single-Agent Phase I Cancer Trials

Arif Manji et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Add to Collection

Article Oncology

Survival of Patients in a Phase 1 Clinic The M. D. Anderson Cancer Center Experience

Jennifer Wheler et al.

CANCER (2009)

Add to Collection

Article Oncology

Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience

H-T Arkenau et al.

BRITISH JOURNAL OF CANCER (2008)

Add to Collection

Article Oncology

Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy

A. Italiano et al.

ANNALS OF ONCOLOGY (2008)

Add to Collection

Article Medicine, General & Internal

Risks and benefits of phase 1 oncology trials, 1991 through 2002

E Horstmann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection

Article Medicine, General & Internal

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials

TG Roberts et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.